The global Dissolving Microarray Patches market size is predicted to grow from US$ 208 million in 2025 to US$ 339 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

Dissolving microarray patches are skin-applied patches covered with an array of tiny needles made from water-soluble or biodegradable materials (such as sugars or biocompatible polymers) that contain a drug or vaccine within the needle matrix. When pressed onto the skin, the microneedles painlessly penetrate the outer barrier and then dissolve or swell in the interstitial fluid, releasing the payload into the upper skin layers before the patch backing is removed and discarded. Because the needles do not remain as sharp waste, dissolving microarray patches are being developed to simplify self-administration, improve patient acceptance, and potentially enhance stability and distribution compared with traditional injections, especially for vaccines and other therapies delivered intradermally.

Consumer/cosmetic microarray patches typically cost between $0.75 and $1.60 per patch. Vaccine microarray patches (MAPs) cost between $0.85 and $5.00 per dose/patch.

Dissolving microarray patches (dissolving microneedle patches) combine a drug product with a single-use microstructured device, so the upstream supply chain spans both pharmaceutical and advanced materials inputs. Upstream starts with the active (vaccine antigen, small molecule, peptide/biologic) and formulation excipients chosen to stabilize the payload in a solid matrix, plus dissolvable microneedle-forming materials such as sugars and water-soluble/biodegradable polymers, along with precision micro-molds/tooling, cleanroom consumables, and packaging materials designed for moisture and oxygen control (foil laminates, desiccants, barrier pouches). Manufacturing typically involves preparing a drug-in-matrix formulation, filling or casting into micro-molds (often with tip-loading or layered casting), controlled drying to lock in dose and stability, demolding and lamination to a backing/adhesive, and rigorous QC for dose uniformity, mechanical strength/insertion performance, residual moisture, particulate/bioburden, and stability, followed by validated packaging and distribution that often emphasizes humidity protection. Downstream, products move through a combination-product pathway into clinical supply and, when commercial, into channels such as immunization programs, clinics, pharmacies, and at-home self-administration, with logistics and training shaped by whether an applicator is needed, how the patch is disposed (minimal sharps), and how performance is verified in real-world use.

United States market for Dissolving Microarray Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Dissolving Microarray Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Dissolving Microarray Patches is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Dissolving Microarray Patches players cover Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

Infinity Market Research newest research report, the ?Dissolving Microarray Patches Industry Forecast? looks at past sales and reviews total world Dissolving Microarray Patches sales in 2025, providing a comprehensive analysis by region and market sector of projected Dissolving Microarray Patches sales for 2026 through 2032. With Dissolving Microarray Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dissolving Microarray Patches industry.

This Insight Report provides a comprehensive analysis of the global Dissolving Microarray Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dissolving Microarray Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Dissolving Microarray Patches market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dissolving Microarray Patches and breaks down the forecast by Microneedle Material, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dissolving Microarray Patches.

This report presents a comprehensive overview, market shares, and growth opportunities of Dissolving Microarray Patches market by product type, application, key manufacturers and key regions and countries.

Segmentation by Microneedle Material:

Hyaluronic Acid

Taurine

Triple-helical Collagen

Segmentation by Type:

    Fast-dissolving Microneedles
    Sustained/Controlled-release Soluble Microneedles

Segmentation by Application:

    Medical
    Cosmetics

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Kindeva
    Raphas
    CosMED Pharmaceutical
    Vaxess Technologies
    Micron Biomedical
    LTS Lohmann Therapie-Systeme
    ArrayPatch
    CeraVx
    Zhongke Microneedle (Beijing) Technology
    Zhuhai Youwe Biotechnology
    Youwei (Zhuhai) Biotechnology
    WCC Biomedical
    Hisamitsu Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dissolving Microarray Patches market?
What factors are driving Dissolving Microarray Patches market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dissolving Microarray Patches market opportunities vary by end market size?
How does Dissolving Microarray Patches break out by Microneedle Material, by Application?